U.S. markets closed

  • S&P 500

    4,109.31
    +58.48 (+1.44%)
     

  • Dow 30

    33,274.15
    +415.12 (+1.26%)
     

  • Nasdaq

    12,221.91
    +208.43 (+1.74%)
     

  • Russell 2000

    1,802.48
    +34.10 (+1.93%)
     

  • Crude Oil

    75.70
    +1.33 (+1.79%)
     

  • Gold

    1,987.00
    -10.70 (-0.54%)
     

  • Silver

    24.24
    +0.25 (+1.03%)
     

  • EUR/USD

    1.0847
    -0.0062 (-0.56%)
     

  • 10-Yr Bond

    3.4940
    -0.0570 (-1.61%)
     

  • GBP/USD

    1.2332
    -0.0058 (-0.47%)
     

  • USD/JPY

    132.7970
    +0.1080 (+0.08%)
     

  • Bitcoin USD

    28,596.81
    +536.73 (+1.91%)
     

  • CMC Crypto 200

    621.79
    +7.58 (+1.23%)
     

  • FTSE 100

    7,631.74
    +11.31 (+0.15%)
     

  • Nikkei 225

    28,041.48
    +258.55 (+0.93%)
     

GeoVax to Present at the 2023 BIO CEO & Investor Conference

GeoVax, Inc.
·2 min read
GeoVax, Inc.
GeoVax, Inc.

ATLANTA, GA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will present at the 2023 BIO CEO & Investor Conference taking place in-person in New York City at the New York Marriott Marquis and virtually on February 6-9, 2023.

BIO CEO & Investor Conference

Date: Tuesday, February 7, 2023

Time: 3:45 PM EST

An on-demand video presentation will also be available for conference participants during the event.

GeoVax will also conduct one-on-one meetings during the conference. For more information or to schedule a meeting, please visit the conference page here or email Investor Relations at govx@cg.capital.

About GeoVax

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s lead infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine targeting high-risk immunocompromised patient populations. Currently in two Phase 2 clinical trials, GEO-CM04S1 is being evaluated as a single-dose, COVID-19 vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient. In addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. GeoVax has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information, visit our website: www.geovax.com.

Contact:
Rich Cockrell
CG Capital
404-736-3838
govx@cg.capital


Recommended Stories

  • One of the world’s richest men knows why Silicon Valley Bank really failed: ‘People on iPhones’

    Stephen Schwartzman, worth $42 billion and at the head of a firm managing almost $1 trillion, says social media is what doomed the bank.

  • Procrastinators, Rejoice: The 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years

    With a yield of 9.62%, the recently expired Series I bond was understandably popular. With interest rates rising, bond funds are down this year and banks continue to offer miserly rates on deposit accounts. So it's no wonder that a … Continue reading → The post It Pays to Procrastinate: The New 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years appeared first on SmartAsset Blog.

  • Schwab Hit by Worst Month Since 1987 Amid Cash Sorting Woes

    (Bloomberg) -- Charles Schwab Corp.’s worst month in more than 35 years has sparked a debate among analysts as to whether the brokerage giant has been unfairly punished by investors amid growing fears about the US banking sector.Most Read from BloombergTrump Faces Fingerprints, Mug Shot After Dramatic IndictmentParents Are Paying Consultants $750,000 to Get Kids Into Ivy League SchoolsWorld’s Top-Rated Airport Sees Immigration System RestoredFlight to Money Funds Is Adding to the Strains on Smal

  • Dow Jones Rises 150 Points After Cool Inflation Data; 6 Stocks To Buy And Watch

    The Dow Jones rose Friday after key inflation data, with the release of the PCE price index, the Fed's preferred measure of inflation.

  • Baby Boomers, You Need This Much Money to Retire Comfortably

    The Baby Boomer generation is reaching retirement age in record numbers. With more Boomers retiring on a daily basis, it helps to understand how prepared they are to leave their jobs for good. In this article, we’ll discuss the average … Continue reading → The post Average Retirement Savings for Baby Boomers appeared first on SmartAsset Blog.

  • A $200,000 Annuity Will Pay Out This Much a Month

    An annuity can be an appealing option to build your retirement nest egg. Adding guaranteed retirement income to your retirement can give you financial stability. But the exact amount that you'll get from an annuity each month will vary. Let's … Continue reading → The post How Much Does a $200,000 Annuity Pay Per Month? appeared first on SmartAsset Blog.

  • Virgin Orbit’s sudden collapse is the latest in a series of high-risk failures by Richard Branson

    The satellite deployment startup founded by Branson is letting go of the bulk of its staff, citing an “inability to secure meaningful funding.”

  • Here’s What Retirement Looks Like in America in Six Charts

    Americans spend decades saving for retirement, never quite sure how much is enough or what sort of life that money will ultimately buy. To benchmark your retirement plans—including your savings and spending and how you spend your time—one place to start is by looking at how your numbers stack up against Americans overall. The biggest source of retirement income for many Americans is the nest egg built up during their careers.

  • Warren Buffett and Morgan Stanley Have One Thing in Common: They Both Like These 2 Stocks

    Investors looking for alpha in an uncertain market environment could do worse than following in the footsteps of legendary stock pickers and probably none can match Warren Buffet’s reputation. Not for nothing the “Oracle of Omaha” is considered one of the all-time greats and for nearly 60 years, between 1965 and 2022, his Berkshire Hathaway firm’s returns have doubled those of the S&P 500. So, it’s definitely worth nosing through Buffett’s portfolio to see which stocks he currently holds. And wh

  • Japan's Toyota hands St Petersburg plant over to Russian state

    MOSCOW (Reuters) -Russia and Toyota said on Friday that the Japanese carmaker's factory in St Petersburg had been handed over to state entity NAMI, with Moscow snapping up more assets from global automakers leaving Russia over the conflict in Ukraine. "Toyota's production site in St Petersburg has... been transferred to the state," Russia's Ministry of Industry and Trade said in a statement. The company said in September it had decided to stop vehicle production in Russia due to the interruption in supplies of key materials and parts.

  • Nomura Says US Money Supply Plunge Is ‘Elephant in the Room’ for Markets

    (Bloomberg) -- A Nomura Holdings Inc. strategist is warning that investors are overlooking a crucial clue as they grapple with the path of US inflation and the Federal Reserve’s response. Most Read from BloombergTrump Faces Fingerprints, Mug Shot After Dramatic IndictmentWorld’s Top-Rated Airport Sees Immigration System RestoredHow King Charles Got Thrown Into Disney’s Fight With Florida Governor DeSantisTrump to Be Arraigned Next Week After Historic IndictmentStocks Rally as Traders Eye Peak Ra

  • How to make $100,000 or more and pay no income taxes

    Here’s how to earn a six-figure income and pay no income taxes on it – totally legally.

  • GE Stock Breaks Out To New High After Soaring More Than 45% — Is It A Buy?

    General Electric will emerge as an aviation and defense pure play in early 2024 after completing its big breakup. Is GE stock a buy as it breaks out to multiyear highs? GE News The company remains on track to spin off its energy business, as GE Vernova, in early 2024.

  • Does Snowflake Inc. (SNOW) Have the Potential to Rally 33.64% as Wall Street Analysts Expect?

    The average of price targets set by Wall Street analysts indicates a potential upside of 33.6% in Snowflake Inc. (SNOW). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

  • Can I Retire Off The Interest I Made Investing $2 Million?

    For older Americans, living off the interest and returns of your retirement account is how retirement is structured. The goal is that by the time you hit your late 60s you will ideally have enough saved up to coast indefinitely. … Continue reading → The post How Much Interest Does $2 Million Pay Monthly? appeared first on SmartAsset Blog.

  • Bear of the Day: Advanced Micro Devices (AMD)

    This stock looks very top heavy with the topline expected to contract this year and margins shrinking

  • Activision Stock Is Too Cheap: Analysts. They Expect Sale to Microsoft to Close.

    Wall Street "currently undervalues" the likelihood that regulators will allow the merger to be completed, according to New Street Research.

  • Can I Retire at 65 with $2.5 Million?

    For most people, it will be little or no problem to retire at age 65 if they have $2.5 million in savings. This amount of capital invested prudently is likely to provide sufficient income for a lifestyle comfortable enough to … Continue reading → The post Is $2.5 Million Enough to Retire at 65? appeared first on SmartAsset Blog.

  • Three Stocks Turn $10,000 To $25,265 In Just 3 Months

    Investors enjoyed a small S&P 500 rally in March. But there were much more lucrative places to put money in the month.

  • As Nvidia Stock Firms Up, Option Trade Could Return Nearly $300

    With positive flow in both stocks in the technology sector and options making more bullish bets, it's the ideal time to take a look at Nvidia.